Emerging preclinical modulators developed for F508del-CFTR have the potential to be effective for ORKAMBI resistant processing mutants

Autor: Laselva, Onofrio, Bartlett, Claire, Popa, Alec, Ouyang, Hong, Gunawardena, Tarini N.A., Gonska, Tanja, Moraes, Theo J., Bear, Christine E.
Zdroj: In Journal of Cystic Fibrosis January 2021 20(1):106-119
Databáze: ScienceDirect
Externí odkaz: